ROCK SPRINGS CAPITAL MANAGEMENT LP Prelude Therapeutics Incorporated Transaction History

ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio value:

$0
portfolio value

ROCK SPRINGS CAPITAL MANAGEMENT LP quarter portfolio value change:

+26.63%
quarter

Prelude Therapeutics Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -368.95K shares -1.92M $6.61 0
Q2 2022 share 0.00% 0 shares -620K $5.22 368.95K
Q1 2022 share 0.00% 0 shares -2.04M $6.9 368.95K
Q4 2021 share Increase +1.82% 6.6K shares -6.73M $12.76 368.95K
Q3 2021 share Decrease -5.23% -20K shares 377K $31.25 362.35K
Q2 2021 share Increase +1.10% 4.16K shares -5.44M $28.63 382.35K
Q1 2021 share Increase +4.95% 17.83K shares -9.39M $43.33 378.19K
Q4 2020 share Increase +0.03% 100 shares 14.92M $71.55 360.36K
Q3 2020 share Increase 0.00% 360.26K shares 10.85M $30.13 360.26K